BPC-157 vs Semax
Extensively Studied vs Well Studied
compatible Both support neuroplasticity through different mechanisms.
Molecular Data
BPC-157 Semax
Weight 1,419.53 Da 813.93 Da
Half-life <30 minutes 0.5-2 hours
Chain 15 amino acids 7 amino acids
Type Pentadecapeptide ACTH(4-10) synthetic analog
Key Benefits
BPC-157
01 Accelerated tendon, ligament, muscle, and bone healing
02 Localized tissue repair with direct targeting
03 Superior bioavailability
04 Anti-inflammatory effects
05 Angiogenesis promotion
06 Gastric and intestinal protection
Semax
01 Rapid brain delivery via intranasal route
02 Rapidly increases BDNF levels
03 Extensive clinical research in Russia
04 Easy self-administration
05 Modulates dopamine and serotonin systems
06 Neuroprotective effects
Dosing Protocols
BPC-157
250-500mcg / Once or twice daily
Tendon/Joint healing 250-500 mcg 1-2x daily
Serious injury 500-1000 mcg 2x daily
General healing 250-500 mcg 1-2x daily
Maintenance 250 mcg 1x daily
Semax
300-600mcg per dose (up to 1000mcg for intensive use) / 1-2x daily (morning recommended for cognitive boost)
Research protocol 500-750mcg 1x daily
Intensive protocol 750-1000mcg 1-2x daily
Side Effects
BPC-157
Mild injection site redness
Injection site irritation
Possible mild digestive adjustment (oral)
Semax
Mild nasal discomfort (nasal route)
Possible nasal sensation upon administration
Contraindications
Active cancer (due to angiogenic effects)
Pregnancy or breastfeeding
Blood thinners (consult doctor due to angiogenesis)
WADA prohibited for competitive athletes
Pregnancy or breastfeeding
Known peptide allergies
Do not exceed 4-week continuous use without medical supervision
Research Evidence
BPC-157 Semax
Status Extensively Studied Well Studied
References 6 studies 4 studies
Latest January 2025 2021
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.